DrugInfoSys

Plague Vaccine

Drug #2055

Plague vaccine has been used since late 19 century,experience indicates that it reduces incidence and severity of disease resulting from bite of infected fleas.

Primary Characteristics

Non-proprietary name: Plague vaccine.

Molecular structure of Plague Vaccine

Pharmacokinetics

None recorded.

Advertisement

Indications

Plague Vaccine is primarily indicated in conditions like Plague.

Contraindications

Plague Vaccine is contraindicated in conditions like Hypersensitivity.

Dosage

Plague Vaccine's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
0.2 mL0.2 mLIMSecond dose: 1 month later after the first dose.
0.2 mL0.2 mLIMThird dose: 5 months later after the second dose.
0.2 mL0.2 mLIMBooster dose at 1- to 2-year intervals if exposure continues.
1 mL1 mLIMFirst dose:
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

3 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Plague Vaccine in overdosage may give rise to further complications which include Erythema , Hypersensitivity.

Plague Vaccine is known to cause more or less tolerable side effects which are usually transient. These include Fever, Headache, Lymphadenopathy, Malaise.

Warnings / Precautions

Patients who have had severe or local systemic reactions to plague vaccine should not be revaccinated.

Interference in Pathology

Plague Vaccine may interfere in the diagnosis of Suppression of tuberculosis skin test.

Available Brands

None recorded.

Drug Classification

  1. 1.19.3.2Vaccines for specific groups of individuals